What Is Early-Onset Alzheimer’s?

Alzheimer’s disease develops when neurons (nerve cells) in the brain stop functioning, lose connections with other neurons, and eventually die.
Early-onset (also called younger-onset) Alzheimer’s and late-onset Alzheimer’s disease usually affect the brain in similar ways, but the issues each raises for the person who has it — from getting an accurate diagnosis to planning for the future — can be very different.
Signs and Symptoms of Early-Onset Alzheimer’s Disease
For most people, the symptoms of early-onset Alzheimer’s mirror those of the late-onset kind, with memory loss usually the first sign of a problem.
- Forgetting important information
- Asking repeatedly for the same information
- Trouble following basic instructions or tasks
- Forgetting the date or season
- Forgetting where you are, or how you got there
- Vision problems, such as depth perception
- Difficulty following conversations or finding words
- Withdrawing at work or in social situations
- Changes in mood or personality
- Poor judgment or uninhibited behavior
- Severe memory loss
- Deep confusion about where you are or life events
- Difficulty with talking, walking, or swallowing
- Having suspicions about family, friends, or caregivers
- Severe mood swings or changes in behavior
Causes and Risk Factors of Early-Onset Alzheimer’s Disease
For most people with early-onset or late-onset Alzheimer’s, the disease appears to be caused by a combination of genetics, lifestyle, and environmental influences interacting in ways that are still not clearly understood.
Researchers have made progress in identifying genes, passed on in families, that raise the risk of both early-onset and late-onset Alzheimer’s.
A variant of a gene called apolipoprotein E (APOE) increases the odds of developing Alzheimer’s in people of all ages, though it does not mean someone will definitely get the disease. People with two copies of this variant, APOE e4, are even more likely to develop Alzheimer’s (one copy is inherited from each parent).
Studies show that the brains of people with Alzheimer’s — including early-onset Alzheimer’s — contain a large amount of specific proteins in what are known as plaques and tangles.
How Is Early-Onset Alzheimer’s Disease Diagnosed?
An early-onset Alzheimer’s diagnosis can be difficult because doctors don’t typically look for the disease in younger people.
To understand what’s causing your symptoms, a doctor should conduct a thorough investigation that includes a detailed family and personal health history, physical and neurological tests, a cognitive assessment, and possibly a brain-imaging scan.
Treatment and Medication Options for Early-Onset Alzheimer’s Disease
- donepezil (Aricept)
- rivastigmine (Exelon)
- galantamine (Razadyne)
- memantine (Namenda)
- donepezil and memantine (Namzaric)
- lecanemab (Leqembi)
- donanemab (Kisunla)
Early-Onset Alzheimer’s Disease Prognosis
There’s no cure for Alzheimer’s disease, at any age. But getting a diagnosis as soon as possible may lead to more effective treatment, helping you treat your cognitive symptoms and possibly delaying progression of the disease.
Research and Statistics: How Many People Have Early-Onset Alzheimer’s Disease?
The Impact of Early-Onset Alzheimer’s Disease on Your Family
People who develop Alzheimer’s disease in their thirties, forties, or fifties face unique social, emotional, and financial challenges.
- Be open about the changes in your health and life.
- Take steps to address your child’s emotional needs, such as meeting with a counselor who focuses on helping families cope with chronic illness.
- Make sure your child’s teachers and school social workers are aware of what’s happening.
- Stay involved in your child’s life and plan activities you can still do together. If driving is no longer possible for you, explore other ways to get around.
- Humor helps. Find things you can laugh about together.
- Record your thoughts and feelings in a journal or on video or audio for your child to have later in life.
The Financial Implications of Early-Onset Alzheimer’s
People with early-onset Alzheimer’s disease may face a daunting financial future, particularly if their job is their main source of income.
Those who are still working may be eligible for disability benefits or may be able to use benefits offered under the federal Family and Medical Leave Act, which allows up to 12 weeks of unpaid, job-protected leave each year for family and medical reasons with continuation of group health insurance coverage.
People who need to leave their job may be able to retain employer-sponsored healthcare coverage for as long as 36 months (depending on the circumstances) under the federal law COBRA.
Pension plans and retirement accounts can typically be drawn from before retirement age if you have a disability as defined under the plan or account’s guidelines.
The Takeaway
- Early-onset Alzheimer’s is a rare form of the disease that causes loss of cognitive function beginning in a person’s fifties, forties, or even thirties.
- In most cases, there is no clear cause of early-onset Alzheimer’s. But sometimes a single inherited genetic variant causes the condition, which may be the case if you have a strong family history of Alzheimer’s.
- There’s no cure for early-onset Alzheimer’s, but medical treatments and lifestyle measures can help you preserve cognitive function and quality of life for as long as possible.
Common Questions & Answers
Resources We Trust
- Cleveland Clinic: Early-Onset Alzheimer’s Disease
- Mayo Clinic: Alzheimer’s Genes: Are You at Risk?
- Alzheimer’s Association: If You Have Younger-Onset Alzheimer's Disease
- Alzheimers.gov: Planning After a Dementia Diagnosis
- Indiana University School of Medicine: LEADS: Investigating Early-Onset Alzheimer’s Disease
Additional reporting by Quinn Phillips.
- Alzheimer’s Disease Facts and Figures. Alzheimer’s Association.
- Early-Onset Alzheimer's Disease. Johns Hopkins Medicine.
- What Causes Young-Onset Dementia? Alzheimer’s Society.
- Alzheimer's Disease Genetics Fact Sheet. National Institute on Aging. March 1, 2023.
- If You Have Younger-Onset Alzheimer's Disease. Alzheimer’s Association.
- How Is Alzheimer's Disease Treated? National Institute on Aging. Septemebr 12, 2023.
- Alzheimer's Disease Facts and Figures. Alzheimer’s Association.
- Sirkis DW et al. Dissecting the Clinical Heterogeneity of Early-Onset Alzheimer’s Disease. Nature Portfolio. April 7, 2022.
- Helping Family and Friends. Alzheimer’s Association.
- Compassionate Allowances. Social Security.

David Weisman, MD
Medical Reviewer
David Weisman, MD, is the director of the Clinical Trial Center at Abington Neurological Associates in Pennsylvania, where he has conducted numerous clinical trials into mild cognitive impairment and Alzheimer’s disease to develop disease-modifying drugs.
Dr. Weisman has dedicated his research career toward advancing new therapies for Alzheimer’s disease, focusing on clinical trials for the prevention and treatment of Alzheimer’s disease, mild cognitive impairment, and other dementias, and he devotes his clinical practice to memory and cognitive problems.
He received a bachelor's degree in philosophy from Franklin and Marshall College, then an MD from Penn State College of Medicine. After an internship at St. Mary’s Hospital in San Francisco, he completed his neurology residency at Yale, where he served as chief resident. He then went to the University California in San Diego for fellowship training in Alzheimer’s disease and other dementias.
Weisman has published papers and studies in journals such as Neurology, JAMA Neurology, Stroke, and The New England Journal of Medicine, among others.

Pamela Kaufman
Author
Pamela Kaufman assigns and edits stories about infectious diseases and general health topics and strategizes on news coverage. She began her journalism career as a junior editor on the health and fitness beat at Vogue, followed by a long stint at Food & Wine, where she rose through the ranks to become executive editor. Kaufman has written for Rutgers University and Fordham Law School and was selected for a 2022 Health Journalism Fellowship from the Association of Health Care Journalists and the Centers for Disease Control and Prevention (CDC).
Kaufman enjoys going on restaurant adventures, reading novels, making soup in her slow cooker, and hanging out with her dog. She lives in New York City with her husband and two kids.